Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Users can note which content they would like to view more frequently. Instagram is handing users some control in deciding what content they see. The social media giant is allowing users to have a say ...

After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...

In Hans Christian Andersen's folktale, The Emperor's New Clothes, when a child cries out that the emperor is naked, he isn't revealing a secret. Everyone already knows it. What changes in that instant ...

Introduction: Parkinson’s disease (PD) is the fastest-growing neurodegenerative disorder, with subtle gait changes such as reduced vertical ground-reaction forces (VGRF) often preceding motor symptoms ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

The current data export is perfect for saving URLs listed by the Canvas API endpoints. However, it misses pages that are only accessible from hyperlinks within other Canvas pages. Depending on the ...

ABSTRACT: In the past decade, Internet Of Things (IOT) technology has become one of the fastest-growing and most widely used technologies and is rapidly becoming a basic feature of global civilization ...

Abstract: Feature selection for high-risk disease diagnosis is critical for accurate risk assessment, yet existing methods fail to incorporate medical domain knowledge, potentially leading to ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...